TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24246908

Group type: EXPERIMENTAL
Intervention: Physiotherapy screening
Number of subjects: 203

Group type: COMPARATOR
Intervention: Standard practice
Number of subjects: 203
Study: 22184366

Group type: EXPERIMENTAL
Intervention: Mailed notification of the fracture sent to primary care physicians (n = 1363)
Number of subjects: 4264

Group type: EXPERIMENTAL
Intervention: Notifications sent to both physicians and patients (n = 1421)
Number of subjects: 4264

Group type: COMPARATOR
Intervention: Usual care (n = 1480)
Number of subjects: 4264

Group type: EXPERIMENTAL
Intervention: Combined groups 2 and 3
Number of subjects: 4264

Group type: EXPERIMENTAL
Intervention: Group 2 (physician notification)
Number of subjects: 4264

Group type: EXPERIMENTAL
Intervention: Group 3 (physician and patient notification)
Number of subjects: 4264
Study: 19159026

Group type: EXPERIMENTAL
Intervention: Computerized device (Wand, Milestone Scientific)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional technique
Number of subjects: 104
Study: 17034977

Group type: EXPERIMENTAL
Intervention: High-performance liquid chromatography method for SMX and TMP determination
Number of subjects: 0
Study: 16277783

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation (4.2 g/d)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control oil
Number of subjects: 53
Study: 11897986

Group type: EXPERIMENTAL
Intervention: Budesonide (400 microg intranasally once daily)
Number of subjects: 143

Group type: COMPARATOR
Intervention: Cetirizine (10 mg orally once daily)
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Budesonide (14-day courses as needed)
Number of subjects: 143
Study: 10212740

Group type: EXPERIMENTAL
Intervention: Deluded participants
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Depressed participants
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 60
Study: 7573647

Group type: EXPERIMENTAL
Intervention: Closed kinetic chain exercises using elastic tubing (Sport Cord)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Open kinetic chain exercises using conventional physical therapy equipment
Number of subjects: 100
Study: 2110972

Group type: EXPERIMENTAL
Intervention: IFN-gamma (0.03 mg/m2, 0.3 mg/m2, 1 mg/m2, 3 mg/m2)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: IFN-gamma
Number of subjects: 21
Study: 506644

Group type: EXPERIMENTAL
Intervention: 8 grams of lecithin administered orally
Number of subjects: 25

Group type: COMPARATOR
Intervention: 2 grams of placebo administered orally
Number of subjects: 25
Study: 30653242

Group type: EXPERIMENTAL
Intervention: Aprepitant 80 mg/day for 4 weeks
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo for 4 weeks
Number of subjects: 58
Study: 27671621

Group type: EXPERIMENTAL
Intervention: Integrated Pulmonary Index (IPI) group
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control group (blinded recording of capnography)
Number of subjects: 170

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: IPI group
Number of subjects: 170

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 170
Study: 26349127

Group type: EXPERIMENTAL
Intervention: Waterpik Water Flosser (WF) plus a manual toothbrush
Number of subjects: 69

Group type: COMPARATOR
Intervention: Sonicare Air Floss Pro (AFP) plus a manual toothbrush
Number of subjects: 69
Study: 23132349

Group type: EXPERIMENTAL
Intervention: Redo cryoballoon ablation
Number of subjects: 47
Study: 21514017

Group type: EXPERIMENTAL
Intervention: Obeldicks light intervention (physical activity training, nutrition education, behavior counseling)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Obeldicks light intervention
Number of subjects: 76
Study: 19658274

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate infusion for 10-14 days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group (no magnesium sulfate infusion)
Number of subjects: 22
Study: 16675938

Group type: EXPERIMENTAL
Intervention: Cisatracurium (0.15 mg/kg initial dose, 0.03 mg/kg maintenance)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Vecuronium (0.1 mg/kg initial dose, 0.02 mg/kg maintenance)
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Cisatracurium
Number of subjects: 177

Group type: COMPARATOR
Intervention: Vecuronium
Number of subjects: 177
Study: 12145008

Group type: EXPERIMENTAL
Intervention: High-isoflavone soyfood diet (50 g soy protein and 73 mg isoflavones daily)
Number of subjects: 41

Group type: EXPERIMENTAL
Intervention: Low-isoflavone soyfood diet (52 g soy protein and 10 mg isoflavones daily)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Both soy diets (high and low isoflavone)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Soy diets (high and low isoflavone)
Number of subjects: 41
Study: 10099907

Group type: EXPERIMENTAL
Intervention: Magnesium (70 mmol infused over 24 h)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 8651412

Group type: EXPERIMENTAL
Intervention: Energy expenditure during pregnancy
Number of subjects: 317

Group type: EXPERIMENTAL
Intervention: Increased basal metabolic rate
Number of subjects: 317
Study: 2110336

Group type: EXPERIMENTAL
Intervention: Atropine/2-PAM chloride
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat-humidity (95 degrees F/60% RH)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Heat-humidity (70 degrees F/30% RH)
Number of subjects: 0
Study: 382381

Group type: EXPERIMENTAL
Intervention: Corticosteroids
Number of subjects: 0
Study: 29284183

Group type: EXPERIMENTAL
Intervention: Peanut oral food challenge (OFC)
Number of subjects: 96
Study: 26867046

Group type: EXPERIMENTAL
Intervention: Standard care consisting of chemotherapy followed by endocrine therapy.
Number of subjects: 350

Group type: COMPARATOR
Intervention: Oncotype DX test used to assign patients to treatment.
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Standard care if 'recurrence score' (RS) was > 25 or endocrine therapy alone if RS was ≤ 25.
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Multiparameter analysis performed on 302 tumour samples.
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Health economics modelling for multiparameter testing.
Number of subjects: 350
Study: 25616289

Group type: EXPERIMENTAL
Intervention: Huai Qi Huang granules plus glucocorticoid
Number of subjects: 42

Group type: COMPARATOR
Intervention: Glucocorticoid alone
Number of subjects: 42
Study: 23731228

Group type: EXPERIMENTAL
Intervention: Newhints intervention (home visits by trained volunteers)
Number of subjects: 15615

Group type: COMPARATOR
Intervention: Control zones
Number of subjects: 15615
Study: 20054285

Group type: EXPERIMENTAL
Intervention: Sequential therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonbismuth quadruple therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard triple therapy
Number of subjects: 0
Study: 18239640

Group type: EXPERIMENTAL
Intervention: Orlistat
Number of subjects: 306

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 306

Group type: EXPERIMENTAL
Intervention: Orlistat and Placebo
Number of subjects: 306
Study: 16382603

Group type: EXPERIMENTAL
Intervention: 3D displays with appropriate cues (e.g., shadows)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Orientation icon and ExoVis displays
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combined displays (2D/3D)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clip plane displays
Number of subjects: 0
Study: 12752488

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 8 mg/day
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 10218722

Group type: EXPERIMENTAL
Intervention: Propranolol, 160 mg/day (n = 37)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Atenolol, 100 mg/day (n = 38)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Bisoprolol, 10 mg/day (n = 39)
Number of subjects: 152

Group type: EXPERIMENTAL
Intervention: Celiprolol, 400 mg/day (n = 38)
Number of subjects: 152
Study: 10165968

Group type: EXPERIMENTAL
Intervention: Telephone mammography counseling
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Telephone counseling and a letter
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 90
Study: 2213773

Group type: EXPERIMENTAL
Intervention: Clotrimazole (20 mg/kg/day) 2 days a week for 12 weeks
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 666929

Group type: EXPERIMENTAL
Intervention: Extradural analgesia
Number of subjects: 21

Group type: COMPARATOR
Intervention: Narcotic analgesia
Number of subjects: 21
Study: 31347385

Group type: EXPERIMENTAL
Intervention: Cediranib alongside chemotherapy followed by placebo maintenance (arm B)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cediranib throughout both periods (arm C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo during chemotherapy and maintenance (arm A)
Number of subjects: 0
Study: 29273007

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m2 plus gemcitabine 1000 mg/m2 on days 1, 8, and 15 every 4 weeks
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: nab-paclitaxel 125 mg/m2 plus gemcitabine 1000 mg/m2
Number of subjects: 83
Study: 26012890

Group type: EXPERIMENTAL
Intervention: Online CBT for insomnia
Number of subjects: 63

Group type: COMPARATOR
Intervention: Waiting-list control
Number of subjects: 63
Study: 23725564

Group type: EXPERIMENTAL
Intervention: Active-choice condition (able to choose story components)
Number of subjects: 26

Group type: COMPARATOR
Intervention: No-choice condition (story components were preselected)
Number of subjects: 26
Study: 21964428

Group type: EXPERIMENTAL
Intervention: NaHCO3 ingestion at 60 minutes before exercise (H1)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: NaHCO3 ingestion at 120 minutes before exercise (H2)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: NaHCO3 ingestion at 180 minutes before exercise (H3)
Number of subjects: 8
Study: 19445661

Group type: EXPERIMENTAL
Intervention: Prophylactic cholecystectomy during standard surgery for curable gastric cancer (subtotal or total gastrectomy)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard gastric surgery only
Number of subjects: 0
Study: 17868430

Group type: EXPERIMENTAL
Intervention: Apixaban 5 mg q.d.
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Apixaban 10 mg b.i.d.
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Apixaban 20 mg b.i.d.
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Enoxaparin 30 mg b.i.d.
Number of subjects: 1238

Group type: COMPARATOR
Intervention: Warfarin (titrated to INR 1.8-3.0)
Number of subjects: 1238

Group type: EXPERIMENTAL
Intervention: Apixaban (all doses)
Number of subjects: 1238
Study: 15135472

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB) using a peritumoural injection technique with blue dye and radiolabelled colloid mapping
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Sentinel node biopsy (SNB)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Standard axillary treatment after SNB
Number of subjects: 75
Study: 12503706

Group type: EXPERIMENTAL
Intervention: Fluticasone propionate (FP) 250 microg, twice daily for 12 weeks
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo, twice daily for 12 weeks
Number of subjects: 68
Study: 10187069

Group type: EXPERIMENTAL
Intervention: Quality improvement strategies including development of leadership skills, focus on internal quality, ongoing training and staff development, and efficient use of resources.
Number of subjects: 0
Study: 8715262

Group type: EXPERIMENTAL
Intervention: Evaluation of training by microcomputers
Number of subjects: 16

Group type: COMPARATOR
Intervention: Noncomputer assisted evaluation
Number of subjects: 16
Study: 31899848

Group type: EXPERIMENTAL
Intervention: s.c. nadroparin (171 IU/kg/d)
Number of subjects: 178
Study: 29386889

Group type: EXPERIMENTAL
Intervention: UMEC/VI 62.5/25 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UMEC 62.5 μg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: VI 25 μg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27067889

Group type: EXPERIMENTAL
Intervention: Financial incentive programme (Nourishing Start for Health - NOSH) for up to 6 months duration, delivered by healthcare professionals
Number of subjects: 10833

Group type: COMPARATOR
Intervention: Usual care (no offer of NOSH intervention)
Number of subjects: 10833
Study: 26333499

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (1 g/(kg.h) for 10 min, then 0.3 g/(kg.h) for 20 min)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Midazolam (0.5 mg/kg for 60 s, then 0.04 mg/(kg.h) for 20 min)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control group (no drug)
Number of subjects: 90
Study: 22940561

Group type: EXPERIMENTAL
Intervention: Opioids alone
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: BZDs concurrent with opioids
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: BZDs alone
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Neither opioids nor BZDs
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Combination of BZDs and opioids
Number of subjects: 115
Study: 20626357

Group type: EXPERIMENTAL
Intervention: Red LED-powered transillumination (TM group, n=67)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Usual method (UM group, n=69)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Red LED-powered transillumination (TM group, n=44)
Number of subjects: 136
Study: 19571699

Group type: EXPERIMENTAL
Intervention: 23-hour-stay laparoscopic colectomy
Number of subjects: 10
Study: 16458681

Group type: EXPERIMENTAL
Intervention: Gatifloxacin 0.3% eyedrops (GAT group)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Ciprofloxacin 0.3% eyedrops (CIP group)
Number of subjects: 104
Study: 15239087

Group type: EXPERIMENTAL
Intervention: Endoscopic variceal banding ligation (VBL)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Propranolol (PPL)
Number of subjects: 152
Study: 11297596

Group type: EXPERIMENTAL
Intervention: Calcium (1200 mg) plus Vitamin D(3) (800 IU)
Number of subjects: 148

Group type: COMPARATOR
Intervention: Calcium (1200 mg/day)
Number of subjects: 148
Study: 9279723

Group type: EXPERIMENTAL
Intervention: Procalcitonin (ProCT) measurement
Number of subjects: 155
Study: 8282390

Group type: EXPERIMENTAL
Intervention: Phenobarbitone
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 3730140

Group type: EXPERIMENTAL
Intervention: Analytic instruction
Number of subjects: 26

Group type: COMPARATOR
Intervention: Holistic instruction
Number of subjects: 26
Study: 31606265

Group type: EXPERIMENTAL
Intervention: Anti-IL-17A treatment
Number of subjects: 150

Group type: COMPARATOR
Intervention: Cyclosporine treatment
Number of subjects: 150
Study: 28316267

Group type: EXPERIMENTAL
Intervention: Integrated Psychostimulation Program (IPP), 90 min/d, 4 d/week for 8 weeks
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Computerized Cognitive Training (CCT), 60 min/d, 4 d/week for 8 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 26841367

Group type: EXPERIMENTAL
Intervention: Individual participant data NMA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aggregate data NMA
Number of subjects: 0
Study: 24907778

Group type: EXPERIMENTAL
Intervention: Receiving multiple HIV prevention messages (about PrEP, nPEP, rectal microbicides, and condoms)
Number of subjects: 803

Group type: COMPARATOR
Intervention: Receiving one, two, or four HIV prevention messages
Number of subjects: 803
Study: 22705148

Group type: EXPERIMENTAL
Intervention: Mild to moderate cognitive impairment
Number of subjects: 173

Group type: COMPARATOR
Intervention: Male gender
Number of subjects: 173

Group type: COMPARATOR
Intervention: Low BMI
Number of subjects: 173

Group type: COMPARATOR
Intervention: Baseline 25‐hydroxyvitamin D level
Number of subjects: 173
Study: 20502997

Group type: EXPERIMENTAL
Intervention: Gain-framed messages
Number of subjects: 249

Group type: COMPARATOR
Intervention: Loss-framed messages
Number of subjects: 249
Study: 18720689

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg daily plus oral levamisole 2.5 mg/kg/wk (up to 150 mg/wk)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Doxycycline 100 mg daily
Number of subjects: 60
Study: 16003426

Group type: EXPERIMENTAL
Intervention: Computerised matching method using digital images
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional matching method simulated in a phantom head
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both methods (computer and conventional)
Number of subjects: 10
Study: 12462431

Group type: EXPERIMENTAL
Intervention: Amoxycillin/clavulanic acid (AMX/CA) 875/125 mg b.i.d. for 14 days
Number of subjects: 206

Group type: COMPARATOR
Intervention: Cefuroxime axetil 500 mg b.i.d. for 14 days
Number of subjects: 206
Study: 10526726

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation (400 IU/day)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 42
Study: 7729023

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter-defibrillators
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Shock or antitachycardia pacing therapy
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Tachycardia rates > 240 beats per minute
Number of subjects: 31
Study: 1781288

Group type: EXPERIMENTAL
Intervention: Huperzine A (0.05 mg bid for 4 weeks for multi-infarct dementia; 0.03 mg bid for 2 weeks for senile and presenile simple memory disorders)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 160
Study: 6452948

Group type: EXPERIMENTAL
Intervention: melphalan
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: 5‐FU and methyl‐CCNU
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: 5‐FU, methyl‐CCNU, and streptozocin
Number of subjects: 127

Group type: COMPARATOR
Intervention: VP‐16‐213
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: two‐ and three‐drug combinations
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: three treatment regimens
Number of subjects: 127
Study: 31651370

Group type: EXPERIMENTAL
Intervention: Etelcalcetide (ETL) administered intravenously after every hemodialysis session for 12 months
Number of subjects: 62

Group type: COMPARATOR
Intervention: Alfacalcidol administered intravenously after every hemodialysis session for 12 months
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Etelcalcetide (ETL)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Alfacalcidol
Number of subjects: 62
Study: 27678271

Group type: EXPERIMENTAL
Intervention: Intraperitoneal bupivacaine (20 mL of 0.5% bupivacaine)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (20 mL of 0.9% normal saline)
Number of subjects: 100
Study: 25251885

Group type: EXPERIMENTAL
Intervention: Supervised Injectable Heroin (SIH)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Supervised Injectable Methadone (SIM)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Optimized Oral Methadone (OOM)
Number of subjects: 127
Study: 24052362

Group type: EXPERIMENTAL
Intervention: Ivabradine (15 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Metoprolol (5-10 mg)
Number of subjects: 120
Study: 23044558

Group type: EXPERIMENTAL
Intervention: Topical mometasone ointment used twice a day for the first month and then once a day for 6 months on a few grafted lesions
Number of subjects: 11
Study: 19571545

Group type: EXPERIMENTAL
Intervention: Ultrasonic scalpel
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional procedure
Number of subjects: 96
Study: 17420168

Group type: EXPERIMENTAL
Intervention: High-GDP PD solution
Number of subjects: 21

Group type: COMPARATOR
Intervention: Low-GDP PD solution
Number of subjects: 21
Study: 15689069

Group type: EXPERIMENTAL
Intervention: 2 mg/kg body weight dihydroartemisinin (DHA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4 mg/kg body weight dihydroartemisinin (DHA)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 4 mg/kg body weight oral artesunate (AS)
Number of subjects: 20

Group type: COMPARATOR
Intervention: oral artesunate (AS)
Number of subjects: 20
Study: 11176547

Group type: EXPERIMENTAL
Intervention: Long instrument
Number of subjects: 290

Group type: EXPERIMENTAL
Intervention: Short instrument
Number of subjects: 290

Group type: COMPARATOR
Intervention: Control group (not asked about expectations)
Number of subjects: 290
Study: 9395031

Group type: EXPERIMENTAL
Intervention: Idarubicin
Number of subjects: 3

Group type: COMPARATOR
Intervention: Daunorubicin
Number of subjects: 3
Study: 7535990

Group type: EXPERIMENTAL
Intervention: Red wine (400 ml per day, 11% alcohol)
Number of subjects: 20

Group type: COMPARATOR
Intervention: White wine (400 ml per day, 11% alcohol)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Both red and white wine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Red wine
Number of subjects: 20

Group type: COMPARATOR
Intervention: White wine
Number of subjects: 20
Study: 3239522

Group type: EXPERIMENTAL
Intervention: OK432 intradermal administration
Number of subjects: 29

Group type: COMPARATOR
Intervention: No adjuvant therapy (Control)
Number of subjects: 29
Study: 31565758

Group type: EXPERIMENTAL
Intervention: UV photo intervention
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Self-compassion exercise with UV photo
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Self-affirmation exercise with UV photo
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Self-compassion and self-affirmation with UV photo
Number of subjects: 167

Group type: COMPARATOR
Intervention: Neutral essay
Number of subjects: 167
Study: 30662331

Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Combination panel of ALT, HOMA-IR, and RBP4
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Ultrasonography
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Metabolomic test
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: Fatty Liver Index (FLI)
Number of subjects: 127
Study: 28612975

Group type: EXPERIMENTAL
Intervention: Endometrial scratch injury (ESI) performed at day 8 or 9 of stimulation phase in the IUI cycle
Number of subjects: 150

Group type: COMPARATOR
Intervention: No intervention (Control group)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Endometrial scratch injury (ESI)
Number of subjects: 150